Dr. Gerald H. Lushington PhD
Chief Scientific Officer (CSO) ORCID: 0000-0001-5821-4253 · USA
Editorial leadership for Journal of Big Data Research ISSN 2768-0207
Research interests
- Computational Chemistry
- Cheminformatics Artificial Intelligence (Ai) For Drug Discovery Neurological
- Immunological Therapeutic Development High Throughput Screening (Hts) Molecular Science
- Chemical Databases
Biography
Dr. Gerald H. Lushington is a highly prolific scientist with a deep background in Computational Chemistry and Cheminformatics. His research involves applying Artificial Intelligence (AI) and bio-inspired methods to accelerate drug discovery, focusing on developing immunotherapeutic and neurological drug candidates. He specializes in the design and implementation of chemical databases and software tools crucial for efficient preclinical pharmaceutical research. He plays a key role in academic publishing as the Editor-In-Chief of a specialized high-throughput screening journal.
Education Details:
- PhD (Chemistry): University Of New Brunswick, Canada (1995).
Professional Background:
- Chief Scientific Officer (CSO) (Current) - Qnapsyn Biosciences Inc.
- Courtesy Appointment - Kansas State University.
Achievements:
- Led development of technological bases and pipelines for neurological therapeutic intervention.
- Published extensively across diverse areas of molecular science and data analysis.
Current Research Projects:
- AI For Drug Discovery: Application of artificial intelligence and bioinspiration for developing new drug candidates.
- Therapeutic Development: Identifying core neuromedical mechanisms and developing protocols for immunotherapeutic and neurological drugs.
Academic Profiles Of Dr. Gerald H. Lushington
Explore his academic and professional presence across trusted platforms:
Selected publications
- In Vitro, In Vivo and In Silico Assessment of the Antimicrobial and Immunomodulatory Effects of a Water Buffalo Cathelicidin (WBCATH) in Experimental Pulmonary Tuberculosis 2022 cited 8×
- Protein Glycation: An Old Villain is Shedding Secrets 2019 cited 7×
- Prediction of Lupus Classification Criteria via Generative AI Medical Record Profiling Recent 2025 cited 5×
- Impact of a digital platform and flare risk blood biomarker index on lupus: A study protocol design for evaluating self efficacy and disease management Recent 2025 cited 3×
- Occurrence of Antimicrobial Resistance Genes in the Oral Cavity of Cats with Chronic Gingivostomatitis 2021 cited 3×
- Criteria and Protocol: Assessing Generative AI Efficacy in Perceiving EULAR 2019 Lupus Classification Recent 2025
Ranked by citation impact (Crossref) where available, newest otherwise · verified via ORCID.
Considering JBR for your work?
This journal is guided by Dr. Gerald H. Lushington (Chief Scientific Officer (CSO) ORCID: 0000-0001-5821-4253) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.